Alternative approaches to enhance necroptosis signaling in tumor cells may include manipulation of ADAR1, which was shown to mask ZBP1-driven necroptosis,28 or therapeutic induction of IFN-I signaling in the TME as MLKL and other critical components are IFN-stimulated genes.7 Here, MLKL is linked to neoplasm.